ASSERTIO THERAPEUTICS, INC. Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)
ASSERTIO THERAPEUTICS, INC. had Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) of $5.64 million as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:LiabilitiesFairValueDisclosureRecurring · last filed 2017-11-09
- 2017-09-30: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $5.64M.
- 2017-06-30: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $7.36M.
- 2017-03-31: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $8.61M.
- 2016-12-31: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $14.82M.
| Period end | Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) |
|---|---|
| 2017-09-30 | $5.64M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $7.36M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $8.61M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $14.82M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $14.95M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $14.90M 10-Q · filed 2016-08-03 |
| 2015-12-31 | $14.97M 10-Q · filed 2016-11-07 |
| 2013-03-31 | $1.46M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.34M 10-Q · filed 2013-05-09 |
| 2012-09-30 | $1.34M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $1.30M 10-Q/A · filed 2012-08-13 |